Results 11 to 20 of about 18,976 (183)

Pleural mesothelioma metastasis of the scalp

Polish Journal of Pathology
Mesothelioma is a locally aggressive malignant tumor that arises on the mesothelial surfaces of the pleura, peritoneum and tunica vaginalis. There are three histologic subtypes of mesothelioma: epithelioid, biphasic, and sarcomatoid. Pleural mesothelioma
Tugcem Bicak, Selver Ozekinci, İbrahim İbiloğlu   +2 more
doaj   +3 more sources

Integrative Bioinformatics and Machine Learning Approaches for Biomarker and Pathway Discovery in Malignant Pleural Mesothelioma. [PDF]

Cancer Rep (Hoboken)
ABSTRACT Background Malignant pleural mesothelioma (MPM) is a highly aggressive thoracic cancer with limited treatment options and poor prognosis. Aims This study employed an integrative transcriptomic and computational approach to uncover potential biomarkers for MPM.
Rohman ML, Biswas S.
europepmc   +2 more sources

Malignant Pleural Mesothelioma [PDF]

Future Oncology, 2009
Malignant pleural mesothelioma continues to be a challenge. The diagnosis and treatment of patients with malignant pleural mesothelioma requires a multidisciplinary approach. The diagnosis is best made by thoracoscopic biopsy and the aid of immunohistochemistry. Molecular studies identified inactivation of the neurofibromatosis-2 gene and INK4alpha/ARF
Stahel, R A, Felley-Bosco, E, Opitz, I, Weder, W   +3 more
  +8 more sources

Malignant pleural mesothelioma [PDF]

Annals of Oncology, 1998
The incidence of malignant pleural mesothelioma (MPM) has risen for some decades and is expected to peak between 2010 and 2020. Up to now, no single treatment has been proven to be effective and death usually occurs within about 12-17 months after diagnosis. Perhaps because of this poor prognosis, early screening has incited little interest.
P, Baas, H, Schouwink, F A, Zoetmulder
openaire   +4 more sources

Environmental Asbestos Exposure as a Possible Pathway to Early-Onset Pleural Mesothelioma: A Case From Afghanistan and Pakistan to London. [PDF]

Respirol Case Rep
We report a case of a 40‐year‐old male with malignant pleural mesothelioma with no prior occupational exposure to asbestos. Environmental exposure as a cause of MPM may come into focus through migration from high environmental asbestos exposure regions in patients with no known occupational exposure.
Mounouchos S, Aggarwal A, Nafees AA, Johnson E, Cullinan P, Reynolds C.   +5 more
europepmc   +2 more sources

Pleural mesothelioma [PDF]

Cancer, 1976
Seventy-six patients with pleural mesothelioma were seen at Memorial Hospital from 1939 to 1972. There were 10 with benign and 66 with malignant mesotheliomas. The latter were histologically divided into 39 epithelial and 27 fibrosarcomatous types. Main symptoms were chest pain, dyspnea, and cough.
H J, Wanebo, N, Martini, M R, Melamed, B, Hilaris, E J, Beattie   +4 more
openaire   +2 more sources

Mesothelin and osteopontin as diagnostic and prognostic markers of malignant pleural mesothelioma in Egyptian patients undergoing pleurodesis

Egyptian Journal of Chest Disease and Tuberculosis, 2013
Purpose: In malignant pleural mesothelioma (MPM), early assessment of disease status is important. We evaluated the role of mesothelin and osteopontin biomarkers in distinguishing MPM from benign pleural disease. We also, evaluated whether mesothelin and
Fawzy M. Amany, Nagat Ali Mohamed, Reda El-Ghamry, Alaa Brik, Abdel Maged Salem, Amira Shoukry, Azza El-Sebaey   +6 more
doaj   +1 more source

Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion

Thoracic Cancer, 2020
Malignant tumors are often associated with eosinophilic pleural effusion. Here, we encountered a case of interleukin‐5 (IL‐5)‐producing malignant pleural mesothelioma with eosinophilic pleural effusion. The patient was a 50‐year‐old male.
Eiji Takeuchi, Naoki Takahashi, Shun Morizumi, Hiroyuki Tamiya, Hisashi Matsuoka, Naoto Kuroda, Kenji Yorita   +6 more
doaj   +1 more source

Malignant pleural mesothelioma [PDF]

American Journal of Health-System Pharmacy, 2012
PURPOSE The etiology, diagnosis, staging, and management of malignant pleural mesothelioma (MPM) are reviewed, with an emphasis on clinical trials of newer approaches to first-line, second-line, and adjuvant chemotherapy.In the past decade, more effective chemotherapy regimens have been developed for patients with MPM, a rapidly progressing disease ...
Sheree E, Chen, Makala B, Pace
openaire   +4 more sources

Malignant mesothelioma with unexpected contralateral mediastinal shift: a case report

Journal of Medical Case Reports, 2008
Introduction Contralateral mediastinal shift due to pleural mesothelioma tissue, rather than a pleural effusion, is an unusual clinical feature of mesothelioma.
Myerson James S, Nicum Shibani, Sharma Bhupinder, O'Brien Mary ER   +3 more
doaj   +1 more source